This European cancer research Commission has identified 12 key recommendations within a call to action to reimagine cancer research and its implementation in Europe. We hope this call to action will help to achieve our ambitious 70:35 target: 70% average survival for all European cancer patients by 2035.
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission / M. Lawler, L. Davies, S. Oberst, K. Oliver, A. Eggermont, A. Schmutz, C. La Vecchia, C. Allemani, Y. Lievens, P. Naredi, T. Cufer, A. Aggarwal, M. Aapro, K. Apostolidis, A. Baird, F. Cardoso, A. Charalambous, M.P. Coleman, A. Costa, M. Crul, C.L. Dégi, F. Di Nicolantonio, S. Erdem, M. Geanta, J. Geissler, J. Jassem, B. Jagielska, B. Jonsson, D. Kelly, O. Kelm, T. Kolarova, T. Kutluk, G. Lewison, F. Meunier, J. Pelouchova, T. Philip, R. Price, B. Rau, I.T. Rubio, P. Selby, M. Južnič Sotlar, G. Spurrier-Bernard, J.C. van Hoeve, E. Vrdoljak, W. Westerhuis, U. Wojciechowska, R. Sullivan. - In: THE LANCET ONCOLOGY. - ISSN 1470-2045. - 2023:1(2023), pp. e11-e56. [10.1016/S1470-2045(22)00540-X]
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
C. La Vecchia;
2023
Abstract
This European cancer research Commission has identified 12 key recommendations within a call to action to reimagine cancer research and its implementation in Europe. We hope this call to action will help to achieve our ambitious 70:35 target: 70% average survival for all European cancer patients by 2035.
| File | Dimensione | Formato | |
|---|---|---|---|
|
European Groundshot_Lancet.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
5.08 MB
Formato
Adobe PDF
|
5.08 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
